Chronic Kidney Disease Clinical Trials in Chicago, Illinois

6 studies are recruiting for chronic kidney disease in Chicago, Illinois right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

   This study is open to children aged 2 to 17 with chronic kidney disease (CKD). The purpose of this study is to find out if a medicine called empagliflozin helps children and adolescents with CKD. Other goals of the study are to find out how empagliflozin is tolerated and handled by the body in chil…

   Stage

   Phase 3

   Ages

   2 to 17

   Site

   Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois

   Locations

   93 in total

   Run by

   Boehringer Ingelheim

   See if you can join NCT07107945 on ClinicalTrials.gov

2. A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

   This is a Phase III, randomized, double-blind, parallel-group, placebo-controlled multicenter study to investigate outcomes with elecoglipron compared with placebo in participants with CKD with and without T2DM who are on background SGLT2i (dapagliflozin) as GDMT and other SoC treatments for CKD.

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Research Site, Chicago, Illinois

   Locations

   715 in total

   Run by

   AstraZeneca

   See if you can join NCT07753993 on ClinicalTrials.gov

3. Breakthrough - T1DM and Chronic Kidney Disease

   Single arm- subject treated with Tegoprubart and everolimus. The purpose of this research is to gather information on the safety and effectiveness of investigational regimen containing 2 experimental components: * An investigational drug called Tegoprubart and * Human pancreatic islet cells Both Te…

   Stage

   Phase 1

   Ages

   18 to 70

   Site

   The University of Chicago, Chicago, Illinois

   Locations

   2 in total

   Run by

   University of Chicago

   See if you can join NCT07592000 on ClinicalTrials.gov

4. A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort

   This study will evaluate safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single ascending doses (SAD) and multiple ascending doses (MAD) of AZD4248 administered as an oral solution and intravenous (IV) infusion. Additionally, the study investigates the non-interventional f…

   Stage

   Phase 1

   Ages

   18 to 75

   Site

   Research Site, Chicago, Illinois

   Locations

   5 in total

   Run by

   AstraZeneca

   See if you can join NCT07024823 on ClinicalTrials.gov

5. Proteogenomic Monitoring and Assessment of Liver Transplant Recipients

   This study is being done to test blood, urine and tissue samples to see if this can help decide if CKD (Chronic Kidney Disease), AR (Acute Rejection) and HCV (Hepatitis C Virus) can be identified in its early stages. CKD damage to the kidneys, AR and HCV all lower the body's ability to function pro…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Northwestern Memorial Hospital, Chicago, Illinois

   Run by

   Northwestern University

   See if you can join NCT01644903 on ClinicalTrials.gov

6. Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy

   Intensive Patient Referral and Education Program prior to Renal Replacement Therapy (iPREP-RRT) is a 12-week intervention that identifies hospitalized African Americans with advanced chronic kidney disease (CKD) and provides them with hospital- and community-based education, navigation and self-man…

   Stage

   Not phased

   Ages

   18 to 70

   Site

   University of Chicago Medical Center, Chicago, Illinois

   Run by

   University of Chicago

   See if you can join NCT06397456 on ClinicalTrials.gov